CYP cynata therapeutics limited

9.68%

17.0¢

Going forward..., page-1977

First 1977 Last

Share
Profile

Follow
Wasabibarako

13,050 Posts.

788

08/03/23

15:48

Post #: 66662229
Share

Originally posted by viewph: ↑

Congrats to the MSB holders today!

Moving forward with CYP, it seems the company is focused on attaining government grants and university partnerships. Whilst still progressing this route is going to be slow and with many constraints. We might avoid dilution for a while but eventually funds will run low and we may need a CR, early next year?

There is no sign of commercial deals and I'm not even sure if they are actively working on this route anymore. No sign of brokers/analysts/roadshows etc. It seems management tried and failed and are going the route above. With the speed of innovation I fear the slow route may fail, would love to see more commercial activity and some deals!

This model certainly wasn't what I originally invested in anyway. Lets get discussions back on track and productive, thoughts welcome..

Expand

viewph: IMO, it is difficult to be "bullish" on this stock.... In the shorter term (coming 12 - 24 months) the CYP share-price will almost certainly continue to go down further - how low remains to be seen. Not pleasing for certain.

wasa

CYP Price at posting: 28.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 1977 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	23813	3
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

Going forward..., page-1977

Boss extends June win streak with boosted Alta Mesa extraction rates

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Going forward..., page-1977

Top Stories

Boss extends June win streak with boosted Alta Mesa extraction rates

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News